Project IMPACT Immunizations (IMProving America's Communities Together)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 1,080
- Locations
- 8
- Primary Endpoint
- Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs
Study Overview
Brief Summary
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
Detailed Description
This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Individuals eligible to be enrolled in the study include any person at least 18 years of age receiving an influenza vaccination from a participating pharmacy site.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs
Time Frame: through study completion, an average of 6 months
Number and types of vaccines administered
Time Frame: Change from baseline rates at 6 months
Number of unmet vaccination needs identified and met
Time Frame: through study completion, an average of 6 months
Secondary Outcomes
No secondary outcomes reported